| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 09/22/2004 | EP1460067A1 Bicyclic derivative, process for producing the same, and use |
| 09/22/2004 | EP1458686A1 Benzocyclodecane derivatives with antitumor activity |
| 09/22/2004 | EP1458671A1 Prodrugs of excitatory amino acids |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458349A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1283205B1 Naphthol derivatives |
| 09/22/2004 | EP1259495B1 Indane derivatives and their use as cell adhesion inhibitors |
| 09/22/2004 | CN1531530A Novel 2-benzoxazolyl benzene derivatives and their use as UV screening agents |
| 09/22/2004 | CN1530106A Medicine composition for treating diabet mellitus |
| 09/22/2004 | CN1530105A Medicine composition for treating diabets and mellitus |
| 09/22/2004 | CN1167701C Method for preparing oxazolidone amine |
| 09/22/2004 | CN1167690C Preparation of mixtures of benzoxazolyl-stilbene compounds |
| 09/22/2004 | CN1167689C Benzoazole compounds, process for the preparation thereof and herbicides |
| 09/21/2004 | US6794534 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 09/21/2004 | US6794516 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 09/21/2004 | US6794479 Composition of polyepoxide and oxazolidine latent curing agent |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794401 Amino acid phenoxy ethers |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794373 Contraceptive methods using benzimidazolones |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/16/2004 | WO2004078988A1 Process for production of aromatic diols |
| 09/16/2004 | WO2004033652A3 Inhibitors of fatty acid amide hydrolase |
| 09/16/2004 | WO2003072553A8 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181074 Reaction of alkoxyethyleneamine, inversion and cyclization for oxazolidone compounds and inversion |
| 09/16/2004 | US20040180943 Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | DE10308350A1 Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten A process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives |
| 09/15/2004 | EP1456151A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 09/15/2004 | EP1169311A4 Oxazole and thiazole combinatorial libraries |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | CN1529694A Method for preparing |
| 09/15/2004 | CN1528752A Oxazolidine intermediate for preparing taxad alkane |
| 09/15/2004 | CN1166614C Indandione compounds and its preparing process and application |
| 09/10/2004 | WO2004076447A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 09/10/2004 | WO2004076428A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 09/10/2004 | WO2004076427A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 09/10/2004 | WO2004076426A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 09/10/2004 | WO2004076423A1 Growth promotion method |
| 09/10/2004 | WO2004076390A1 Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives |
| 09/10/2004 | WO2004076386A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 09/10/2004 | WO2004075891A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments |
| 09/10/2004 | WO2004075815A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | CA2517575A1 Growth promotion method |
| 09/10/2004 | CA2517386A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 09/10/2004 | CA2517381A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 09/10/2004 | CA2517307A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments |
| 09/10/2004 | CA2516842A1 Hydroxamic acid compounds comprising a bicylic heteroaryl group as hdac inhibitors |
| 09/10/2004 | CA2516657A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 09/10/2004 | CA2516623A1 Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives |
| 09/10/2004 | CA2516620A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 09/10/2004 | CA2516573A1 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/09/2004 | US20040176445 Propionic acid derivatives |
| 09/09/2004 | US20040176424 Insecticide and method of controlling insects |
| 09/09/2004 | DE10308580B3 Verfahren zur elektrophilen Substitution von Thiazolidinen oder Oxazolidinen Method for electrophilic substitution of thiazolidines or oxazolidines |
| 09/08/2004 | EP1453815A1 Metabotropic glutamate receptor-5 modulators |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453788A1 Substituted hydroxyethylamines |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004073606A2 Sulfonamide derivatives as ppar modulators |
| 09/02/2004 | WO2004066964A9 Amino acid phenoxy ethers |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171840 Process for the electrophilic substitution of thiazolidines or oxazolidines |
| 09/02/2004 | US20040171644 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 09/02/2004 | US20040171608 Synthesis of clasto-lactacystin beta-lactone and analogs thereof |
| 09/02/2004 | US20040170863 Organic electroluminescent devices using double-spiro organic compounds |
| 09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | CA2512883A1 Sulfonamide derivatives as ppar modulators |
| 09/01/2004 | EP1452529A1 PRocess for an electrophilic substitution of thiazolidines or oxazolidines |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
| 09/01/2004 | EP1452520A1 A process for the synthesis of sphingosine |
| 09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 09/01/2004 | EP1451164A2 Amide derivatives having improved solubility |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 08/31/2004 | US6784310 Crystals of the compound can be obtained in a stable manner with good workability avoiding an oil formation and scaling and with a large mean crystal particle diameter and good powder characteristics |
| 08/31/2004 | US6784304 Use of optionally n-protected 2,2-dialkyl,4-substituted-5-carboxy-oxadiazolidines in the preparation of c-13 acyloxy sidechain-bearing taxanes such as paclitaxel |
| 08/31/2004 | US6784292 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 08/26/2004 | WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 08/26/2004 | WO2004072068A1 Vanilloid receptor ligands and their use in treatments |
| 08/26/2004 | WO2004072053A1 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 08/26/2004 | WO2004072050A1 Heterocyclic compounds useful as nurr-1 activators |
| 08/26/2004 | WO2004071509A1 Oligodendrocyte differentiation promoters |
| 08/26/2004 | WO2004071448A2 Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| 08/26/2004 | WO2004071447A2 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | WO2004071442A2 Novel bicyclic compounds and compositions |
| 08/26/2004 | WO2004058679A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 08/26/2004 | WO2004047744A3 3-heterocyclic benzylamide derivatives as potassium channel openers |
| 08/26/2004 | US20040167358 Method and reagents for N-alkylating ureides |